A deep-value, high-yield IT-education leader trying to earn a healthcare-and-silver-economy re-rating—while leverage and regulation decide the outcome.
Overview
Neutech Group (9616.HK) is a rebranded evolution of Neusoft Education (name change completed early 2025) moving from a specialized IT higher-education operator into an integrated “Education + Healthcare + Wellness” ecosystem. The company still relies on three private universities for stable tuition-driven cash flows, but is increasingly monetizing its proprietary TOPCARES curriculum framework through a scalable 4S ed-tech licensing model used by hundreds of partner institutions. The strategic inflection came with the mid-2024 acquisition and 2025 consolidation of Neusoft Healthcare Management, adding hospitals (cardiovascular and dental), eldercare, and wellness tourism to address China’s aging-driven “silver economy.” FY2025 delivered rapid top-line expansion (revenue ~RMB 2.255bn, +40%) but also highlighted transition costs: gross margin fell materially (32.3% → 25.2%) and profit attributable to parent dropped sharply as healthcare integration, overhead, and investment spending weighed on earnings. The stock screens as deep value (low P/E, P/B below 1) and offers an exceptionally high dividend yield (16%+), but this appeal is intertwined with high leverage (~138% debt-to-equity) and the need for healthcare assets to reach sustainable profitability over the next several years.